[Retracted] Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: A rationale to combine targeted drugs based on protein expression inhibition profiles.

Auteurs

Aftimos PG, Wiedig M, Fontsa ML, Awada A, Ghanem G, Journe F

  • Date de publication

    Januari 2025
  • Type

    Other
  • Tijdschrift

    Int J Oncol
  • Naam van de onderzoeker

    LANGOUO FONTSA MIREILLE
  • Hôpital

    Institut Jules Bordet
  • Dienst

    Médecine Oncologique
  • PMID

    39575465
  • DOI

    10.3892/ijo.2024.5707